E-MTAB-783 - Gene expression analysis of 789 cancer cell lines using the Affymetrix HT- HG-U133A v2 platform

Status
Released on 14 September 2011, last updated on 2 May 2014
Organism
Homo sapiens
Samples (727)
Array (1)
Protocols (3)
Description
RNA extracted from each cell line was hybridised to the array.
Experiment types
transcription profiling by array, co-expression, disease state, in vivo
Contact
Citations
Systematic identification of genomic markers of drug sensitivity in cancer cells. Garnett MJ, Edelman EJ, Heidorn SJ, Greenman CD, Dastur A, Lau KW, Greninger P, Thompson IR, Luo X, Soares J, Liu Q, Iorio F, Surdez D, Chen L, Milano RJ, Bignell GR, Tam AT, Davies H, Stevenson JA, Barthorpe S, Lutz SR, Kogera F, Lawrence K, McLaren-Douglas A, Mitropoulos X, Mironenko T, Thi H, Richardson L, Zhou W, Jewitt F, Zhang T, O Brien P, Boisvert JL, Price S, Hur W, Yang W, Deng X, Butler A, Choi HG, Chang JW, Baselga J, Stamenkovic I, Engelman JA, Sharma SV, Delattre O, Saez-Rodriguez J, Gray NS, Settleman J, Futreal PA, Haber DA, Stratton MR, Ramaswamy S, McDermott U, Benes CH.
Combinatorial high-throughput experimental and bioinformatic approach identifies molecular pathways linked with the sensitivity to anticancer target drugs. Venkova L, Aliper A, Suntsova M, Kholodenko R, Shepelin D, Borisov N, Malakhova G, Vasilov R, Roumiantsev S, Zhavoronkov A, Buzdin A. :27227-27238 (2015), PMID:26317900
MIAME
PlatformsProtocolsVariablesProcessedRaw
Files